• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Streamline Health Solutions Inc.

    6/2/25 8:04:53 PM ET
    $STRM
    EDP Services
    Technology
    Get the next $STRM alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 7)


    STREAMLINE HEALTH SOLUTIONS INC.

    (Name of Issuer)


    Common Stock, $0.01 par value per share

    (Title of Class of Securities)


    86323X205

    (CUSIP Number)


    Kevin A. McGovern, Esq.
    c/o Harbert Discovery Fund, LP, 2100 Third Avenue North Suite 600
    Birmingham, AL, 35203
    205-987-5500

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    05/29/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    HARBERT DISCOVERY FUND LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:
    (1) Includes 16,666 shares of restricted stock that are held for the benefit of the investors of Harbert Discovery Fund, LP as disclosed in Table I of the Form 4 filed by Kenan Lucas on July 22, 2024.


    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Harbert Discovery Fund GP, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    OO



    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Harbert Fund Advisors, Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ALABAMA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    CO, IA



    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Harbert Management Corporation
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ALABAMA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    CO



    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Jack Bryant
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    IN



    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Kenan Lucas
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    IN



    SCHEDULE 13D

    CUSIP No.
    86323X205


    1 Name of reporting person

    Raymond Harbert
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    338,280.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    338,280.00
    11Aggregate amount beneficially owned by each reporting person

    338,280.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    7.8 %
    14Type of Reporting Person (See Instructions)

    IN



    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, $0.01 par value per share
    (b)Name of Issuer:

    STREAMLINE HEALTH SOLUTIONS INC.
    (c)Address of Issuer's Principal Executive Offices:

    2400 Old Milton Parkway, Box 1353, Alpharetta, GEORGIA , 30009.
    Item 2.Identity and Background
    (a)
    This Schedule 13D is being filed jointly by: (i) Harbert Discovery Fund, LP, a Delaware limited partnership (the "Fund"), (ii) Harbert Discovery Fund GP, LLC, a Delaware limited liability company (the "Fund GP"), (iii) Harbert Fund Advisors, Inc., an Alabama corporation ("HFA"), (iv) Harbert Management Corporation, an Alabama corporation ("HMC"), (v) Jack Bryant, a United States citizen, (vi) Kenan Lucas, a United States citizen, and (vii) Raymond Harbert, a United States citizen. Each of the Fund, the Fund GP, HFA, HMC, Mr. Bryant, Mr. Lucas and Mr. Harbert are referred to as a "Reporting Person" and collectively as the "Reporting Persons." Each of the Reporting Persons is party to that certain Joint Filing Agreement attached hereto as Exhibit A. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D. The Fund is a private investment fund. The Fund GP is the Fund's general partner. HFA is an investment adviser registered with the United States Securities and Exchange Commission and the investment adviser to the Fund. HMC Is the parent of HFA. Mr. Lucas is the Managing Director and Portfolio Manager of the Fund GP. Mr. Bryant is an Executive Vice President and Senior Managing Director of HMC. Mr. Harbert is the Chairman and Chief Executive Officer of HMC and HFA. Set forth on Exhibit B attached hereto is the name and present principal occupation or employment, principal business address and citizenship of the executive officers and directors of HFA and HMC. To the best of the Reporting Persons' knowledge, except as otherwise set forth herein, none of the persons listed on Exhibit B beneficially owns any securities of the Issuer or is a party to any contract, agreement or understanding required to be disclosed herein.
    (b)
    The principal business address for each of the Reporting Persons is 2100 Third Avenue North, Suite 600, Birmingham, Alabama 35203.
    (c)
    The principal business of the Fund is purchasing, holding and selling securities for investment purposes. The principal business of the Fund GP is serving as the general partner of the Fund. The principal business of HMC and its wholly-owned subsidiary HFA is serving as an alternative asset management firm to various private funds, including the Fund. The principal occupation of Mr. Lucas is serving as the Managing Director and Portfolio Manager of the Fund GP and as the portfolio manager for other clients. The principal occupation of Mr. Bryant is serving as an Executive Vice President and Senior Managing Director of HMC. The principal occupation of Mr. Harbert is serving as the Chairman and Chief Executive Officer of HMC and HFA.
    (d)
    No Reporting Person or any person listed on Exhibit B has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). No Reporting Person or any person listed on Exhibit B has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.
    Item 3.Source and Amount of Funds or Other Consideration
     
    The funds for the purchase of the Shares by the Fund came from the working capital of the Fund, over which HFA, HMC, the Fund GP, Jack Bryant, Kenan Lucas and Raymond Harbert, through their roles described above in Item 2(c), exercise investment discretion. No borrowed funds were used to purchase the Shares, other than borrowed funds used for working capital purposes in the ordinary course of business. The total costs of the Shares directly owned by the Fund is approximately $6,074,546.
    Item 4.Purpose of Transaction
     
    There have been no changes from the Schedule 13D Amendment No. 6 filed on August 19, 2021.
    Item 5.Interest in Securities of the Issuer
    (a)
    As of the date hereof, HFA, HMC, Raymond Harbert, the Fund GP, the Fund, Jack Bryant and Kenan Lucas may be deemed to be the beneficial owners of 338,280 Shares, constituting 7.8% of the Shares, based upon 4,331,315* shares outstanding as of the date hereof. HFA has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. HMC has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. The Fund GP has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. The Fund has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. Jack Bryant has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. Kenan Lucas has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. Raymond Harbert has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 338,280 Shares; has the sole power to dispose or direct the disposition of 0 Shares; and has the shared power to dispose or direct the disposition of 338,280 Shares. There have been no transactions by the Reporting Persons in the Shares within the last 60 days. *This outstanding Shares figure reflects the number of outstanding Shares on April 28, 2025, as reported in the Issuer's Form 10-K, filed on May 2, 2025.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
     
    On May 29, 2025, certain of the Reporting Persons entered into a voting and support agreement (the "Voting Agreement") with Mist Holding Co. ("Parent"). Pursuant to the Voting Agreement, certain of the Reporting Persons have agreed, among other things, to vote all Shares owned by them (i) in favor of the approval and adoption of the Agreement and Plan of Merger, dated as of May 29, 2025 (the "Merger Agreement"), by and among the Issuer, Parent and MD BE Merger Sub, Inc. ("Merger Sub") pursuant to which, upon the terms and subject to the condition set forth therein, Merger Sub shall merge with and into the Issuer, with the Issuer continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger," and together with the other transactions contemplated by the Merger Agreement, the "Transaction") and the transactions contemplated thereby, any other matters necessary for the consummation of the Transaction, and any adjournment or postponement of the meeting of holders of Shares to be held for the purpose of voting upon the Transaction if there are not sufficient votes for there to be a quorum or for the approval and adoption of the Merger Agreement, and (ii) against any alternative acquisition proposal from a third party, any action or proposal in furtherance of such an acquisition proposal, and any other actions that are intended to, would reasonably be expected to, result in the conditions to the closing of the Merger not being satisfied or a breach by the Issuer of the Merger Agreement, change in the capitalization of the Issuer or the voting rights of the Issuer's securities, or otherwise impede, interfere with, delay, discourage, adversely affect or inhibit the timely consummation of the Merger; provided, however, that nothing in the Voting Agreement shall affect any actions taken by such Reporting Persons or any of such Reporting Persons' affiliates (or any officer, director or employee thereof) solely in his or her capacity as a director or officer of the Issuer or from complying with his or her fiduciary obligations solely to the extent acting in such person's capacity as a director or officer of the Issuer. The Voting Agreement terminates upon the earliest of the effective time of the Merger, the valid termination of the Merger Agreement in accordance with its terms, the mutual written agreement of Parent and the applicable Reporting Persons to terminate the Voting Agreement and the date on which, subject to the terms of the Voting Agreement, the applicable Reporting Persons deliver written notice to Parent of such Reporting Persons' election, in their sole discretion, to terminate the Voting Agreement following any amendment or modification to the Merger Agreement that reduces the amount of the Merger Consideration (as defined in the Merger Agreement), changes the form of any of the Merger Consideration or otherwise modifies the terms of the Merger Agreement in a manner that is materially adverse to the Issuer's stockholders as a whole.
    Item 7.Material to be Filed as Exhibits.
     
    Exhibit A: Joint Filing Agreement Exhibit B: 2025 Officers and Directors of HFA and HMC

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    HARBERT DISCOVERY FUND LP
     
    Signature:By: Harbert Discovery Fund GP, LLC, its General Partner, By: Harbert Management Corporation, its Managing Member, By /s/ John McCullough
    Name/Title:John McCullough / Executive Vice President and General Counsel
    Date:06/02/2025
     
    Harbert Discovery Fund GP, LLC
     
    Signature:By: Harbert Management Corporation, its Managing Member By /s/ John McCullough
    Name/Title:John McCullough / Executive Vice President and General Counsel
    Date:06/02/2025
     
    Harbert Fund Advisors, Inc.
     
    Signature:By John McCullough, By /s/ John McCullough
    Name/Title:John McCullough / Executive Vice President and General Counsel
    Date:06/02/2025
     
    Harbert Management Corporation
     
    Signature:By John McCullough, By /s/ John McCullough
    Name/Title:John McCullough / Executive Vice President and General Counsel
    Date:06/02/2025
     
    Jack Bryant
     
    Signature:By Jack Bryant, By /s/ Jack Bryant
    Name/Title:Jack Bryant
    Date:06/02/2025
     
    Kenan Lucas
     
    Signature:By Kenan Lucas, By /s/ Kenan Lucas
    Name/Title:Kenan Lucas
    Date:06/02/2025
     
    Raymond Harbert
     
    Signature:By Raymond Harbert, By /s/ Raymond Harbert
    Name/Title:Raymond Harbert
    Date:06/02/2025
    Get the next $STRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRM

    DatePrice TargetRatingAnalyst
    11/21/2022$3.00Buy
    Lake Street
    More analyst ratings

    $STRM
    SEC Filings

    View All

    SEC Form 15-12G filed by Streamline Health Solutions Inc.

    15-12G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/22/25 12:12:26 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form EFFECT filed by Streamline Health Solutions Inc.

    EFFECT - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/18/25 12:15:11 AM ET
    $STRM
    EDP Services
    Technology

    SEC Form EFFECT filed by Streamline Health Solutions Inc.

    EFFECT - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)

    8/18/25 12:15:10 AM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Streamline Health with a new price target

    Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00

    11/21/22 9:57:20 AM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucas Kenan disposed of $1,806,415 worth of shares (338,280 units at $5.34) (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 9:22:15 PM ET
    $STRM
    EDP Services
    Technology

    Chief People Officer Lovvorn Wendy L returned 27,216 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 1:14:58 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form 4 filed by Streamline Health Solutions Inc.

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    8/14/25 1:12:19 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamline Health® Reports Fiscal First Quarter 2025 Financial Results

    ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal first quarter of 2025 which ended April 30, 2025. Fiscal First Quarter Financial Results Total revenue for the first quarter of fiscal 2025 increased approximately 12% to $4.8 million as compared to $4.3 million during the first quarter of fiscal 2024. The change in total revenue was attributable to successful implementation of new SaaS contracts offset by client non-renewals. Saa

    6/16/25 4:05:04 PM ET
    $STRM
    EDP Services
    Technology

    MDaudit and Streamline Health Announce Definitive Merger Agreement

    The combined entity supports healthcare organizations nationwide with an aggregate Net Patient Revenue of more than $300B and brings together best-in-class billing compliance and revenue integrity solutions to empower health systems with actionable foresight and end-to-end visibility. MDaudit to acquire all outstanding shares of Streamline stock for $5.34 per share in cash, a premium of 138% to Streamline's closing price on May 28, 2025. Boston, Mass. and Atlanta, Ga., May 29, 2025 (GLOBE NEWSWIRE) -- MDaudit, an award-winning cloud-based continuous risk monitoring platform that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, and St

    5/29/25 8:00:00 AM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

    ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fourth quarter and fiscal year 2024, which ended January 31, 2025. Management Commentary "As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million to our clients by helping them better control revenue cycle outcomes — and we're just getting started. We're focused on deepening that impact with targeted innovation in fiscal 2025. Our new d

    5/1/25 4:10:58 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Stilwill Benjamin Louis bought $1,008 worth of shares (6,300 units at $0.16), increasing direct ownership by 1% to 611,576 units (SEC Form 4)

    4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)

    9/24/24 4:58:31 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Streamline Health Solutions Inc.

    SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    9/27/23 3:10:25 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Streamline Health Solutions Inc. (Amendment)

    SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    6/22/23 5:20:33 PM ET
    $STRM
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Streamline Health Solutions Inc. (Amendment)

    SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)

    2/3/23 3:17:59 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Leadership Updates

    Live Leadership Updates

    View All

    Streamline Health® Improves Liquidity Position and Appoints New Directors

    Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants Atlanta, GA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM) ("Streamline" or "the Company"), a leading provider of solutions that enable healthc

    2/7/24 4:31:00 PM ET
    $STRM
    EDP Services
    Technology

    $STRM
    Financials

    Live finance-specific insights

    View All

    Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

    ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fourth quarter and fiscal year 2024, which ended January 31, 2025. Management Commentary "As of January 31, 2025, our solutions are delivering an annualized financial impact of more than $210 million to our clients by helping them better control revenue cycle outcomes — and we're just getting started. We're focused on deepening that impact with targeted innovation in fiscal 2025. Our new d

    5/1/25 4:10:58 PM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline

    Net loss of ($2.5 million) during the third quarter of fiscal 2024 compared to a net loss of ($11.9 million) during the third quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany accelerated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the first half of fiscal 2025 ATLANTA, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the third quarter of

    12/16/24 4:33:39 PM ET
    $STRM
    EDP Services
    Technology

    Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance

    ATLANTA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended October 31, 2024 on Monday December 16, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, December 17, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phon

    12/9/24 5:15:00 PM ET
    $STRM
    EDP Services
    Technology